Hua Medicine

Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
285
Ticker
2552
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Hua Medicine Ltd. is a biotechnology company specializing in the development and commercialization of innovative drug therapies, primarily targeting diabetes and related metabolic diseases. Headquarte...

Hua Medicine's GHG Emissions Data Preview

In 2023, Hua Medicine completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Hua Medicine has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Hua Medicine’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Hua Medicine’s data sources below and access millions more through our Disclosure Search.

a. Hua Medicine's ESG Report 2023
a. Hua Medicine's ESG Report 2023
b. Hua Medicine's ESG Report 2022
b. Hua Medicine's ESG Report 2022

Insights into Hua Medicine's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Hua Medicine amounted to 435.747 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Hua Medicine increased by 32.24%, suggesting that the company faced challenges in reducing its emissions from its core operations. a b

Hua Medicine's Scope 1 Emissions Over Time

20212022202305101520tCO2e+13%+12%
  • Total Scope 1
  • Year-over-Year Change

What are Hua Medicine's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Hua Medicine were 19.201 metric tons of CO₂ equivalent (tCO₂e). a

Has Hua Medicine reduced its Scope 1 emissions over time?

Since 2021, Hua Medicine's Scope 1 emissions have increased by 26.41%, reflecting a rising long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2022), Hua Medicine's Scope 1 emissions increased by 11.83%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a b

What are Hua Medicine's Scope 2 emissions?

In 2023, Hua Medicine reported Scope 2 greenhouse gas (GHG) emissions of 416.546 tCO₂e without specifying the calculation method. a

Has Hua Medicine reduced its Scope 2 emissions over time?

Since 2021, Hua Medicine's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Hua Medicine 's emissions have plateaued with no significant change in its energy consumption footprint. a b

Compared to the previous year (2022), Hua Medicine's Scope 2 emissions (Unspecified Calculation Method) rose by 33.37% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a b

What methodology does Hua Medicine use for Scope 2 reporting?

In 2023, Hua Medicine reported its Scope 2 emissions using an unspecified methodology. a

Hua Medicine's Scope 2 Emissions Over Time

2021202220230150300450600tCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Hua Medicine’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Hua Medicine reported Scope 1 greenhouse gas (GHG) emissions of 19.201 tCO₂e and total revenues of USD 12 millions. This translates into an emissions intensity of 1.63 tCO₂e per millions USD. a

Hua Medicine's Scope 1 Emissions Intensity Compared to Peers

102002,00050,000500,000Scope 1 Emissions (tCO2e)2202002,00010,000Revenues (Millions of USD)CCHPDSDCCanSino BiologicsYear: 2023Scope 1: 3,541 tCO2eRevenue: $M 49Scope 1 Intensity: 72.91 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MCCCR Double-CraneYear: 2023Scope 1: 51,608 tCO2eRevenue: $M 1,438Scope 1 Intensity: 35.88 tCO2e/$MHumanwell Healthcare GroupYear: 2023Scope 1: 23,403 tCO2eRevenue: $M 3,451Scope 1 Intensity: 6.78 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,830Scope 1 Intensity: 7.19 tCO2e/$MHHHuadong MedicineYear: 2023Scope 1: 14,289 tCO2eRevenue: $M 5,716Scope 1 Intensity: 2.50 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MYunnan Baiyao GroupYear: 2023Scope 1: 28,983 tCO2eRevenue: $M 5,503Scope 1 Intensity: 5.27 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MFosun PharmaYear: 2024Scope 1: 184,016 tCO2eRevenue: $M 5,627Scope 1 Intensity: 32.70 tCO2e/$MSSSihuan PharmaceuticalYear: 2023Scope 1: 45,602 tCO2eRevenue: $M 286Scope 1 Intensity: 159.27 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MCCChina Resources SanjiuYear: 2024Scope 1: 55,312 tCO2eRevenue: $M 3,784Scope 1 Intensity: 14.62 tCO2e/$MGenor Biopharma HoldingsYear: 2022Scope 1: 18 tCO2eRevenue: $M 3Scope 1 Intensity: 7.17 tCO2e/$MHua MedicineYear: 2023Scope 1: 19 tCO2eRevenue: $M 12Scope 1 Intensity: 1.63 tCO2e/$M

How does Hua Medicine's GHG emissions intensity compare to its peers?

In 2023, Hua Medicine reported a Scope 1 emissions intensity of 1.63 tCO₂e per millions USD. Compared to the peer group median of 27.66 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Hua Medicine rank on GHG emissions intensity within its industry?

In 2023, Hua Medicine ranked 1 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Hua Medicine among the top performers, with one of the lowest emissions intensities relative to peers. a

Want Full Access to Hua Medicine's GHG Emissions Dataset?
Sign Up